Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.16NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
W.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.264.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.21 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.160.20NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.160.19NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.160.12NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AT.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.619.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
P.1.12.1 (Gamma)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.160.22NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AZ.2.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.260NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.456NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.160.16NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.4.16 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.22NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.70NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.42NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.428NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.374NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.63 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.377NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.258.15NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.298NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
C.30.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.76NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.258.11NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.160.31NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.385NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.384NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.160.32NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.338NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BG.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.20.1 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XVNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.38.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.4.1.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.2.80NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.134NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CZ.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BY.1.2.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BM.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BM.2.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CW.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.42NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XAY.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CH.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.46NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used